Brookfield Asset Management Inc. Kymera Therapeutics, Inc. Transaction History

Brookfield Asset Management Inc.

  • $14 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$35.3 - $64.68 $307,780 - $563,944
8,719 Added 42.54%
29,215 $1.24 Million
Q4 2021

Feb 14, 2022
BUY
$49.91 - $65.56 $146,286 - $192,156
2,931 Added 16.69%
20,496 $1.3 Million
Q3 2021

Nov 16, 2021
BUY
$47.8 - $66.66 $839,607 - $1.17 Million
17,565 New
17,565 $1.03 Million

Others Institutions Holding KYMR

# of Institutions
184
Shares Held
64.4M
Call Options Held
50.6K
Put Options Held
81.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.3B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email